PT - JOURNAL ARTICLE AU - Guo, Yihao AU - Zhou, Liangdong AU - Li, Yi AU - Chiang, Gloria C. AU - Liu, Tao AU - Chen, Huijuan AU - Huang, Weiyuan AU - de Leon, Mony J. AU - Wang, Yi AU - Chen, Feng TI - Quantitative transport mapping of multi-delay arterial spin labeling MRI detects early blood perfusion alteration in Alzheimer’s disease AID - 10.1101/2024.03.18.24304481 DP - 2024 Jan 01 TA - medRxiv PG - 2024.03.18.24304481 4099 - http://medrxiv.org/content/early/2024/03/19/2024.03.18.24304481.short 4100 - http://medrxiv.org/content/early/2024/03/19/2024.03.18.24304481.full AB - Background Quantitative transport mapping (QTM) of blood velocity, based on the transport equation has been demonstrated higher accuracy and sensitivity of perfusion quantification than the traditional Kety’s method-based blood flow (Kety flow). This study aimed to investigate the associations between QTM velocity and cognitive function in Alzheimer’s disease (AD) using multiple post-labeling delay arterial spin labeling (ASL) MRI.Methods A total of 128 subjects (21 normal controls (NC), 80 patients with mild cognitive impairment (MCI), and 27 AD) were recruited prospectively. All participants underwent MRI examination and neuropsychological evaluation. QTM velocity and traditional Kety flow maps were computed from multiple delay ASL. Regional quantitative perfusion measurements were performed and compared to study group differences. We tested the hypothesis that cognition declines with reduced cerebral blood flow with consideration of age and gender effects.Results In cortical gray matter (GM) and the hippocampus, QTM velocity and Kety flow showed decreased values in AD group compared to NC and MCI groups; QTM velocity, but not Kety flow, showed a significant difference between MCI and NC groups. QTM velocity and Kety flow showed values decreasing with age; QTM velocity, but not Kety flow, showed a significant gender difference between male and female. QTM velocity and Kety flow in the hippocampus were positively correlated with cognition, including global cognition, memory, executive function, and language function.Conclusion This study demonstrated an increased sensitivity of QTM velocity as compared with the traditional Kety flow. Specifically, we observed only in QTM velocity, reduced perfusion velocity in GM and the hippocampus in MCI compared with NC. Both QTM velocity and Kety flow demonstrated reduction in AD vs controls. Decreased QTM velocity and Kety flow in the hippocampus were correlated with cognitive measures. These findings suggest QTM velocity as an improved biomarker for early AD blood flow alterations.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported in part by the Hainan Province Science and Technology Special Fund (ZDYF2024SHFZ058), the National Natural Science Foundation of China (82271977), the Hainan Academician Innovation Platform Fund, and the Hainan Province Clinical Medical Center, and the NIH of United States R01EB034755, R01AG080011, R01AG057848, R01AG068398, R01AG080011, RF1AG057570, R56AG058913, R01AG057848.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee/IRB of Hainan General Hospital (Hainan Affiliated Hospital of Hainan Medical University) gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.